John I Bell Selected Research

John I Bell Research Topics

10	Infections 01/2023 - 01/2007
5	Multiple Sclerosis 09/2013 - 08/2006
3	COVID-19 01/2022 - 01/2021
2	Reinfection 01/2023 - 10/2021
2	Melanoma (Melanoma, Malignant) 01/2023 - 09/2007
2	Neoplasms (Cancer) 01/2023 - 01/2006
1	Uveal melanoma 01/2023
1	Breakthrough Infections 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Demyelinating Diseases (Demyelinating Disease) 09/2013
1	Necrosis 08/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2012
1	Rheumatoid Arthritis 08/2012
1	Disease Susceptibility (Diathesis) 11/2008
1	Virus Diseases (Viral Diseases) 02/2008
1	HIV Infections (HIV Infection) 01/2007
1	Encephalomyelitis (Myeloencephalitis) 08/2006
1	Hepatitis B 06/2006
1	Severe Acute Respiratory Syndrome 11/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2004
1	Narcolepsy 02/2004
1	Human Influenza (Influenza) 07/2003

5	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
5	VaccinesIBA 01/2023 - 01/2021
5	BNT162 VaccineIBA 01/2022 - 01/2021
4	Peptides (Polypeptides)IBA 01/2023 - 02/2004
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2003
2	AntigensIBA 01/2023 - 09/2007
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
1	tebentafuspIBA 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	EpitopesIBA 01/2022
1	AntibodiesIBA 10/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 11/2016
1	Tumor Necrosis Factor InhibitorsIBA 09/2013
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2012
1	HLA-A Antigens (HLA-A)IBA 11/2008
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2008
1	HLA-A*02:01 antigenIBA 11/2008
1	MART-1 AntigenIBA 09/2007
1	AutoantigensIBA 09/2007
1	AIDS VaccinesIBA 01/2007
1	HLA-DR Antigens (HLA-DR)IBA 10/2006
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 10/2006
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2006
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2006
1	Histocompatibility Antigens Class IIIBA 02/2004